CYP 253 (Gfn 795 PSE 85 795 mg-85 mg)

Pill imprint CYP 253 has been identified as Gfn 795 PSE 85 795 mg-85 mg.

Guaifenesin/pseudoephedrine is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/pseudoephedrine 795 mg-85 mg is not a controlled substance under the Controlled Substance Act (CSA).

Gfn 795 PSE 85

Imprint:

CYP 253

Strength:

795 mg-85 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Rx and/or OTC

Drug Class:

Upper respiratory combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Cypress Pharmaceutical Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.